Circio Holding ASA
Research Circio Holding ASA (CRNA) on Bullrun: market cap NOK 1.77B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCRNA
- ExchangeOL
- CountryNorway
- SectorHealthcare
- IndustryBiotechnology
- CurrencyNOK
- Market capNOK 1.77B
- Financial periodFY2025
- Net income-NOK 45.91M
- Free cash flow-NOK 45.82M
Valuation Snapshot
latest market cap is NOK 1.77B.
About Circio Holding ASA
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a research collaboration with United Immunity Co., Ltd.
Frequently asked questions
What is Circio Holding ASA's market cap?
Circio Holding ASA's market capitalization is NOK 1.77B.
What does Circio Holding ASA do?
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer;